DK2480245T3 - Ny fremgangsmåde til fremstilling af et antimikrobielt peptid - Google Patents

Ny fremgangsmåde til fremstilling af et antimikrobielt peptid

Info

Publication number
DK2480245T3
DK2480245T3 DK10754768.9T DK10754768T DK2480245T3 DK 2480245 T3 DK2480245 T3 DK 2480245T3 DK 10754768 T DK10754768 T DK 10754768T DK 2480245 T3 DK2480245 T3 DK 2480245T3
Authority
DK
Denmark
Prior art keywords
preparing
new method
antimicrobial peptide
antimicrobial
peptide
Prior art date
Application number
DK10754768.9T
Other languages
English (en)
Inventor
Christian Naumer
Michael Krohn
Yvonne Tiffert
Jürgen Eck
Original Assignee
Brain Biotechnology Res & Information Network Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brain Biotechnology Res & Information Network Ag filed Critical Brain Biotechnology Res & Information Network Ag
Application granted granted Critical
Publication of DK2480245T3 publication Critical patent/DK2480245T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK10754768.9T 2009-09-25 2010-09-22 Ny fremgangsmåde til fremstilling af et antimikrobielt peptid DK2480245T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09012228 2009-09-25
PCT/EP2010/063971 WO2011036174A1 (en) 2009-09-25 2010-09-22 A novel method for the production of a antimicrobial peptide

Publications (1)

Publication Number Publication Date
DK2480245T3 true DK2480245T3 (da) 2014-05-26

Family

ID=41668437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10754768.9T DK2480245T3 (da) 2009-09-25 2010-09-22 Ny fremgangsmåde til fremstilling af et antimikrobielt peptid

Country Status (4)

Country Link
US (1) US20120213764A1 (da)
EP (1) EP2480245B1 (da)
DK (1) DK2480245T3 (da)
WO (1) WO2011036174A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160361384A1 (en) * 2013-06-14 2016-12-15 L'oreal Cosmetic use of dermicidin, or analogues or fragments thereof, for the prevention and/or treatment and diagnosis of oily skin and aesthetic skin disorders associated therewith
FR3006897A1 (fr) * 2013-06-14 2014-12-19 Oreal Utilisation cosmetique ou therapeutique, notamment dermatologique de la dermicidine, analogues ou fragments de celle-ci pour prevenir l'apparition d'imperfections, ainsi que pour le traitement et le diagnostic de la peau acneique ou a tendance acneique
FR3011739A1 (fr) * 2013-06-27 2015-04-17 Oreal Utilisation cosmetique de la dermcidine, analogues ou fragments de celle-ci pour prevenir et/ou traiter les odeurs corporelles ainsi que pour le diagnostique des sueurs odorantes
WO2017044476A1 (en) * 2015-09-08 2017-03-16 Massachusetts Institute Of Technology Methods and compositions for recombinase-based genetic diversification
CN106906180A (zh) * 2016-12-28 2017-06-30 里程 一种具有生物活化作用的复合添加剂及其制备方法和用途
EP3360891B1 (en) 2017-02-14 2022-03-30 Karlsruher Institut für Technologie Cell penetrating peptides of human origin
CN115820529A (zh) * 2022-10-21 2023-03-21 江苏亢钧生物科技有限公司 一种提高毕赤酵母表达眼镜王蛇抗菌肽产量的诱导方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE530008A (da) 1953-06-30
US2730457A (en) 1953-06-30 1956-01-10 Ncr Co Pressure responsive record materials
US2730456A (en) 1953-06-30 1956-01-10 Ncr Co Manifold record material
US2800457A (en) 1953-06-30 1957-07-23 Ncr Co Oil-containing microscopic capsules and method of making them
US4001140A (en) 1974-07-10 1977-01-04 Ncr Corporation Capsule manufacture
CH589464A5 (da) 1975-07-11 1977-07-15 Filtrox Maschinenbau Ag
US4100103A (en) 1976-12-30 1978-07-11 Ncr Corporation Capsule manufacture
US4197346A (en) 1978-10-10 1980-04-08 Appleton Papers Inc. Self-contained pressure-sensitive record material and process of preparation
JPS5651238A (en) 1979-10-02 1981-05-08 Fuji Photo Film Co Ltd Production of microminiature capsule
CA2087691A1 (en) 1992-01-23 1993-07-24 Peter Critchley Cosmetic compositon
JPH10139817A (ja) 1996-11-08 1998-05-26 Kuraray Co Ltd 微小カプセルの製法
US6080418A (en) 1997-04-07 2000-06-27 3M Innovative Properties Company Suspensions of microcapsules containing biologically active ingredients and adhesive microspheres
DE10000223A1 (de) 2000-01-05 2001-07-12 Basf Ag Mikrokapselzubereitungen und Mikrokapseln enthaltende Wasch- und Reinigungsmittel
DE10000621A1 (de) 2000-01-10 2001-07-12 Basf Ag Niedrigviskose, formaldehydreduzierte Dispersionen von Mikrokapseln aus Melamin-Formaldehyd-Harzen
US6248703B1 (en) 2000-03-15 2001-06-19 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Extruded soap and/or detergent bar compositions comprising encapsulated benefit agent
DE10129983A1 (de) * 2001-06-13 2003-01-30 Univ Eberhard Karls Antimikrobiell wirkendes Peptid
US6917809B2 (en) 2001-10-23 2005-07-12 Motorola, Inc. Method for automatically sorting the neighbor list of a cell in a communications system
EP1438126B1 (en) 2001-10-25 2012-07-04 Basf Se Process for the preparation of microcapsules
US7608696B2 (en) * 2001-10-26 2009-10-27 Dana-Farber Cancer Institute, Inc. IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
US7846895B2 (en) * 2006-09-06 2010-12-07 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof

Also Published As

Publication number Publication date
WO2011036174A1 (en) 2011-03-31
EP2480245B1 (en) 2014-05-07
EP2480245A1 (en) 2012-08-01
US20120213764A1 (en) 2012-08-23

Similar Documents

Publication Publication Date Title
HUS1900023I1 (hu) Plazma kallikreint kötõ proteinek
DK2662352T3 (da) Fremgangsmåde til fremstilling af phenylacetamidforbindelse
IL249285A0 (en) Transaminase polypeptides
DK2310034T3 (da) Peptider til behandling af beta-amyloidose
HUE043607T2 (hu) Parazitaellenes dihidroazol készítmények
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
DK2509427T3 (da) Fremgangsmåder til fremstilling af GH8-xylanasevarianter
DK2440157T3 (da) Linseleveringssystem
DK3395372T3 (da) System til afgivelse af glutathion-baseret medikament
HUE036081T2 (hu) Mirac proteinek
DK2498829T3 (da) Komponent til sårforbinding
EP2509515A4 (en) WITHERS
DK2283904T3 (da) Komponentsystem
DK2442791T3 (da) Former til dosering af apixaban
EP2523606C0 (en) TRANSCORPOREAL DELIVERY SYSTEM
BRPI1007295A (pt) peptídeos antibióticos
DK2490963T3 (da) Patron til tilberedning af drikke
DK2443154T3 (da) Bispecifikke antigenbindingsproteiner
DK2391225T3 (da) Fremgangsmåde til fremstilling af lactoferrin
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
DK2482768T3 (da) Intrauterint system
DK2398817T4 (da) Fremgangsmåde til rensning af lipopeptider
EP2437770A4 (en) ANTIMICROBIAL PEPTIDES
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
HUE042614T2 (hu) Felnyílómozgató-rendszer